Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
Enveric Biosciences’ CBD-Based Product Reduces Dermatitis Severity In Animal Study [Benzinga]
November 18, 2021
CBD News Roundup: Study Shows Effectiveness of CBDistillery Sleep Product [CBD Insider]
November 16, 2021
Enveric Biosciences Sees Opportunity In Both Cannabinoids, Psychedelics [Green Market Report]
November 16, 2021
Highlights on Enveric Biosciences [Psychedelic Spotlight]
October 25, 2021
Enveric Enters Next Phase Of CBD Cancer Treatment Trial [Candid Chronicle]
July 12, 2021
Enveric Biosciences and MagicMed [The Green Rush Podcast]
July 8, 2021
Enveric Biosciences – Clinical Development of Cannabinoids and Psychedelics [Health Professionals Radio]
June 29, 2021
Texas the Latest State to Legalize Psychedelic Medical Research [Bloomberg Law]
June 23, 2021
Enveric Biosciences + MagicMed on Recent Acquisition Announcement, Mind and Body Clinical Pipeline [SNN]
June 9, 2021
Exclusive: MagicMed CEO On Psychedelics Company’s ‘Secret Sauce,’ M&A Deal With Enveric Biosciences [Benzinga]
June 4, 2021
‹
1
…
5
6
7
8
9
…
11
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact